Software

OpenText slammed after restructuring announcement

Open Text CEO Mark Barrenechea.

Shares of OpenText (TSX:OTC) are getting hit today after the company announced a comprehensive restructuring that will reduce the size of its workforce by five per cent.

CEO Mark Barrenechea, whom the company also announced is returning to work after leaving for leukemia treatment, said the move would not impact the Waterloo-based company’s topline.

“Effective immediately, we are announcing a simplification of our business structure around enterprise, information exchange and analytics, as well as a new global technical services organization,” he said. “This structure will allow us to scale as we continue to acquire complementary businesses over time, and will provide additional focus on winning the customer and capturing the lifetime value of that relationship. As a result of the restructuring, we expect to save approximately $50-million in annualized operating expense, accretive to fiscal year 2016 earnings and with little to no impact on revenues.”

OpenText says it will focus on its cloud business strategy to deliver growth. Management says it want to be a leader in the Enterprise Information Management (EIM) space. The company notes that its cloud business now accounts for nearly a third of its overall topline, a number that was zero just three years ago.

OpenText says it will face a pretax restructuring charge of about $25-million, mostly owing to employee severance arrangements and facility expenses. The company yesterday shuffled the deck on its management, parting ways with Jon Hunter, executive vice-president, worldwide field operations, and appointing James McGourlay, senior vice-president, global technical services, and Simon Harrison, senior vice-president, enterprise sales, amongst other appointments.

At press time, shares of OpenText on the TSX were down 13.1% to $51.97.

Tagged with: OTC
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

View Comments

  • no no... please don't use "CEO's health issues" to create sympathy. It's looks too bad for company's reputation. Simple - Stop buying more companies if you don't know what you are doing with employees or how to use Govt (people's) money.

Recent Posts

Cannara Biotech is a buy, Research Capital says

Research Capital analyst Greg McLeish said in a July 29 update that Cannara Biotech (Cannara Biotech Stock Quote, Chart, News,… [Read More]

17 hours ago

Ahead of Q2 results, is Tantalus Systems a buy?

Beacon Securities analyst Gabriel Leung noted in a July 30 report that Tantalus Systems (Tantalus Systems Holding Stock Quote, Chart,… [Read More]

17 hours ago

Sanuwave Health is a buy, Roth Capital says

Roth Capital Markets is initiating coverage of Sanuwave Health (Sanuwave Health Stock Quote, Chart, News, Analysts, Financials NASDAQ:SNWV) with a… [Read More]

17 hours ago

Shoulder Innovations is an IPO to watch, this analyst says

Roth Capital Markets analyst Jason Wittes noted in a July 28 pre-IPO report that Shoulder Innovations, a new entrant in… [Read More]

17 hours ago

Nextracker wins price target raise at Roth

Roth Capital Markets analyst Philip Shen said in a July 28 earnings preview that Nextracker (Nextracker Stock Quote, Chart, News,… [Read More]

18 hours ago

Telus is my top telecom stock, Brian Madden says

Brian Madden, Chief Investment Officer at First Avenue Investment Counsel, said on BNN Bloomberg’s Market Call on July 25 that… [Read More]

2 days ago